APP and neuroblastoma: Posiphen and phenserine are a new class of small compounds that reduce the development of Aβ in the brain while blocking the APP 5′-UTR IRE RNA-directed translation of APP in astrocytoma and neuroblastoma cell lines and in rats [141].